CalciMedica, Inc. (CALC) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 La Jolla, CA, 美国. 现任CEO为 A. Rachel Leheny.
CALC 拥有 IPO日期为 2023-06-14, 14 名全职员工, 在 NASDAQ Capital Marke, 市值为 $10M.
CalciMedica, Inc., a clinical-stage biotechnology company, focuses on developing therapies for life-threatening inflammatory diseases with unmet needs. Its proprietary technology targets the inhibition of calcium release-activated (CRAC) channels designs to modulate the immune response and protect against tissue cell injury in life-threatening inflammatory diseases. Its lead product candidate is Auxora, a proprietary intravenous-formulated CRAC channel inhibitor for the treatment of acute pancreatitis, asparaginase-associated acute pancreatitis, and acute kidney injury. The company is based in La Jolla, California.
